DENNER ALEXANDER J — SEC Form 4 filings
SEC reporting owner CIK 1361754. 15 Form 4 filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-03-19 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 2 filings — 8,349,095 shares, $48,925,890 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 1,196,746 shares @ $17.52 ($20,964,237) in Innoviva, Inc., filed 2025-03-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Innoviva, Inc. (INVA) | 10% owner | 2 | — | 3 legs · 1,618,295 sh · $28,395,442 | — |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | Director | 13 | — | 2 legs · 6,730,800 sh · $20,530,448 | 14 |
Form 4 filings — DENNER ALEXANDER J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/award (A): 3,694 @ $0 | EDGAR |
| 2026-06-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/award (A): 4,065 @ $0 · Grant/award (A): 63,481 @ $0 | EDGAR |
| 2026-03-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/award (A): 4,451 @ $0 · Sale (S): 6,725,000 @ $3.05 · Sale (S): 5,800 @ $3.31 | EDGAR |
| 2025-12-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 4,178 @ $0 | EDGAR |
| 2025-09-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/award (A): 11,718 @ $0 | EDGAR |
| 2025-06-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 24,193 @ $0 | EDGAR |
| 2025-06-12 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2025-04-04 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 10,416 @ $0 | EDGAR |
| 2025-03-17 | 4/A | Innoviva, Inc. (INVA) jointly with Sarissa Capital Management LP | Holdings only — no transactions reported | EDGAR |
| 2025-03-06 | 4 | Innoviva, Inc. (INVA) jointly with Sarissa Capital Management LP | Sale (S): 151,175 @ $17.63 · Sale (S): 270,374 @ $17.63 · Sale (S): 1,196,746 @ $17.52 | EDGAR |
| 2024-12-18 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 4,249 @ $0 | EDGAR |
| 2024-09-18 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 3,282 @ $0 | EDGAR |
| 2024-06-21 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 24,311 @ $0 | EDGAR |
| 2024-06-18 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 2,572 @ $0 | EDGAR |
| 2024-03-19 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 1,662 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1361754 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →